Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 145

1.

The schizophrenia susceptibility gene neuregulin 1 modulates tolerance to the effects of cannabinoids.

Boucher AA, Hunt GE, Micheau J, Huang X, McGregor IS, Karl T, Arnold JC.

Int J Neuropsychopharmacol. 2011 Jun;14(5):631-43. doi: 10.1017/S146114571000091X. Epub 2010 Aug 12.

PMID:
20701826
2.

Heterozygous neuregulin 1 mice are more sensitive to the behavioural effects of Delta9-tetrahydrocannabinol.

Boucher AA, Arnold JC, Duffy L, Schofield PR, Micheau J, Karl T.

Psychopharmacology (Berl). 2007 Jun;192(3):325-36. Epub 2007 Feb 28.

PMID:
17333138
3.

A follow-up study: acute behavioural effects of Delta(9)-THC in female heterozygous neuregulin 1 transmembrane domain mutant mice.

Long LE, Chesworth R, Arnold JC, Karl T.

Psychopharmacology (Berl). 2010 Aug;211(3):277-89. doi: 10.1007/s00213-010-1896-6. Epub 2010 Jun 23.

PMID:
20571781
4.

Transmembrane domain Nrg1 mutant mice show altered susceptibility to the neurobehavioural actions of repeated THC exposure in adolescence.

Long LE, Chesworth R, Huang XF, McGregor IS, Arnold JC, Karl T.

Int J Neuropsychopharmacol. 2013 Feb;16(1):163-75. doi: 10.1017/S1461145711001854. Epub 2012 Jan 9.

PMID:
22226049
5.

Heterozygous neuregulin 1 mice display greater baseline and Delta(9)-tetrahydrocannabinol-induced c-Fos expression.

Boucher AA, Hunt GE, Karl T, Micheau J, McGregor IS, Arnold JC.

Neuroscience. 2007 Nov 23;149(4):861-70. Epub 2007 Aug 28.

PMID:
17905522
6.

Altered motor activity, exploration and anxiety in heterozygous neuregulin 1 mutant mice: implications for understanding schizophrenia.

Karl T, Duffy L, Scimone A, Harvey RP, Schofield PR.

Genes Brain Behav. 2007 Oct;6(7):677-87. Epub 2007 Feb 13.

7.

Disruption to social dyadic interactions but not emotional/anxiety-related behaviour in mice with heterozygous 'knockout' of the schizophrenia risk gene neuregulin-1.

O'Tuathaigh CM, O'Connor AM, O'Sullivan GJ, Lai D, Harvey R, Croke DT, Waddington JL.

Prog Neuropsychopharmacol Biol Psychiatry. 2008 Feb 15;32(2):462-6. Epub 2007 Sep 29.

PMID:
17980471
8.

Neuregulin 1 hypomorphic mutant mice: enhanced baseline locomotor activity but normal psychotropic drug-induced hyperlocomotion and prepulse inhibition regulation.

van den Buuse M, Wischhof L, Lee RX, Martin S, Karl T.

Int J Neuropsychopharmacol. 2009 Nov;12(10):1383-93. doi: 10.1017/S1461145709000388. Epub 2009 Apr 29.

PMID:
19400983
9.

Distinct neurobehavioural effects of cannabidiol in transmembrane domain neuregulin 1 mutant mice.

Long LE, Chesworth R, Huang XF, Wong A, Spiro A, McGregor IS, Arnold JC, Karl T.

PLoS One. 2012;7(4):e34129. doi: 10.1371/journal.pone.0034129. Epub 2012 Apr 3.

10.

Female neuregulin 1 heterozygous mice require repeated exposure to Δ⁹-tetrahydrocannabinol to alter sensorimotor gating function.

Spencer JR, Chohan TW, Karl T, Arnold JC.

Pharmacopsychiatry. 2013 Nov;46(7):286-91. doi: 10.1055/s-0033-1355390. Epub 2013 Oct 8.

PMID:
24105081
11.

Adolescent neuregulin 1 heterozygous mice display enhanced behavioural sensitivity to methamphetamine.

Spencer JR, Darbyshire KM, Boucher AA, Arnold JC.

Prog Neuropsychopharmacol Biol Psychiatry. 2012 Dec 3;39(2):376-81. doi: 10.1016/j.pnpbp.2012.07.014. Epub 2012 Jul 29.

PMID:
22850204
12.

Do transmembrane domain neuregulin 1 mutant mice exhibit a reliable sensorimotor gating deficit?

Karl T, Burne TH, Van den Buuse M, Chesworth R.

Behav Brain Res. 2011 Oct 1;223(2):336-41. doi: 10.1016/j.bbr.2011.04.051. Epub 2011 May 13.

PMID:
21605597
13.

Phenotypic characterization of spatial cognition and social behavior in mice with 'knockout' of the schizophrenia risk gene neuregulin 1.

O'Tuathaigh CM, Babovic D, O'Sullivan GJ, Clifford JJ, Tighe O, Croke DT, Harvey R, Waddington JL.

Neuroscience. 2007 Jun 15;147(1):18-27. Epub 2007 May 21.

PMID:
17512671
14.

Altered behavior and alcohol tolerance in transgenic mice lacking MAO A: a comparison with effects of MAO A inhibitor clorgyline.

Popova NK, Vishnivetskaya GB, Ivanova EA, Skrinskaya JA, Seif I.

Pharmacol Biochem Behav. 2000 Dec;67(4):719-27.

PMID:
11166062
15.

A behavioural comparison of acute and chronic Delta9-tetrahydrocannabinol and cannabidiol in C57BL/6JArc mice.

Long LE, Chesworth R, Huang XF, McGregor IS, Arnold JC, Karl T.

Int J Neuropsychopharmacol. 2010 Aug;13(7):861-76. doi: 10.1017/S1461145709990605. Epub 2009 Sep 29.

PMID:
19785914
16.

Partial genetic deletion of neuregulin 1 modulates the effects of stress on sensorimotor gating, dendritic morphology, and HPA axis activity in adolescent mice.

Chohan TW, Boucher AA, Spencer JR, Kassem MS, Hamdi AA, Karl T, Fok SY, Bennett MR, Arnold JC.

Schizophr Bull. 2014 Nov;40(6):1272-84. doi: 10.1093/schbul/sbt193. Epub 2014 Jan 17.

17.

The distribution of cannabinoid-induced Fos expression in rat brain: differences between the Lewis and Wistar strain.

Arnold JC, Topple AN, Mallet PE, Hunt GE, McGregor IS.

Brain Res. 2001 Dec 7;921(1-2):240-55. Erratum in: Brain Res 2002 May 3;934(2):168.

PMID:
11720732
18.

Cognition in transmembrane domain neuregulin 1 mutant mice.

Duffy L, Cappas E, Lai D, Boucher AA, Karl T.

Neuroscience. 2010 Oct 27;170(3):800-7. doi: 10.1016/j.neuroscience.2010.07.042. Epub 2010 Aug 1.

PMID:
20678553
19.

Genetic vs. pharmacological inactivation of COMT influences cannabinoid-induced expression of schizophrenia-related phenotypes.

O'Tuathaigh CM, Clarke G, Walsh J, Desbonnet L, Petit E, O'Leary C, Tighe O, Clarke N, Karayiorgou M, Gogos JA, Dinan TG, Cryan JF, Waddington JL.

Int J Neuropsychopharmacol. 2012 Oct;15(9):1331-42. doi: 10.1017/S1461145711001581. Epub 2011 Nov 11.

PMID:
22074909
20.

Behavioral profile of a heterozygous mutant mouse model for EGF-like domain neuregulin 1.

Duffy L, Cappas E, Scimone A, Schofield PR, Karl T.

Behav Neurosci. 2008 Aug;122(4):748-59. doi: 10.1037/0735-7044.122.4.748.

PMID:
18729627
Items per page

Supplemental Content

Write to the Help Desk